Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.49)
# 2,384
Out of 5,049 analysts
270
Total ratings
50%
Success rate
-1.53%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $410 → $405 | $362.61 | +11.69% | 13 | Oct 31, 2025 | |
| ILMN Illumina | Maintains: Outperform | $132 → $142 | $116.86 | +21.51% | 9 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $88 → $92 | $84.15 | +9.33% | 15 | Oct 31, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $88 → $92 | $74.30 | +23.82% | 5 | Oct 30, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $17 → $18 | $15.00 | +20.00% | 11 | Oct 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $16 → $14 | $11.58 | +20.90% | 12 | Oct 30, 2025 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $155 → $168 | $172.64 | -2.69% | 8 | Oct 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $142 | $125.80 | +12.88% | 17 | Oct 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $106 → $104 | $103.18 | +0.79% | 14 | Oct 7, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $46 → $42 | $30.06 | +39.72% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $565.24 | +4.38% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $106 | $91.69 | +15.61% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $235.08 | +21.24% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,420.35 | -1.43% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $535 → $450 | $538.82 | -16.48% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $175 | $181.10 | -3.37% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $68 | $69.59 | -2.28% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $213.83 | +14.58% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $98.84 | +11.29% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $17.94 | +72.80% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $128 → $140 | $146.08 | -4.16% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $69 → $78 | $74.11 | +5.25% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $46.43 | +16.30% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $31.18 | +28.29% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $35 → $33 | $30.18 | +9.34% | 8 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $90.42 | +17.23% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $31.44 | +46.31% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.57 | +16.73% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $12.00 | +150.00% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $367.34 | -3.36% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $73.76 | +116.92% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $179.04 | +61.97% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.04 | +573.08% | 1 | May 31, 2022 |
Stryker
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $362.61
Upside: +11.69%
Illumina
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $116.86
Upside: +21.51%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $84.15
Upside: +9.33%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $74.30
Upside: +23.82%
Bausch + Lomb
Oct 30, 2025
Maintains: Outperform
Price Target: $17 → $18
Current: $15.00
Upside: +20.00%
Avantor
Oct 30, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $11.58
Upside: +20.90%
J.B. Hunt Transport Services
Oct 16, 2025
Maintains: Outperform
Price Target: $155 → $168
Current: $172.64
Upside: -2.69%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $144 → $142
Current: $125.80
Upside: +12.88%
Zimmer Biomet Holdings
Oct 7, 2025
Maintains: In-Line
Price Target: $106 → $104
Current: $103.18
Upside: +0.79%
Twist Bioscience
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $30.06
Upside: +39.72%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $565.24
Upside: +4.38%
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $91.69
Upside: +15.61%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $235.08
Upside: +21.24%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,420.35
Upside: -1.43%
Oct 7, 2025
Maintains: In-Line
Price Target: $535 → $450
Current: $538.82
Upside: -16.48%
Oct 7, 2025
Maintains: In-Line
Price Target: $185 → $175
Current: $181.10
Upside: -3.37%
Oct 7, 2025
Maintains: Outperform
Price Target: $64 → $68
Current: $69.59
Upside: -2.28%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $213.83
Upside: +14.58%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $98.84
Upside: +11.29%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $17.94
Upside: +72.80%
Oct 7, 2025
Maintains: In-Line
Price Target: $128 → $140
Current: $146.08
Upside: -4.16%
Oct 7, 2025
Upgrades: Outperform
Price Target: $69 → $78
Current: $74.11
Upside: +5.25%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $46.43
Upside: +16.30%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $31.18
Upside: +28.29%
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $30.18
Upside: +9.34%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $90.42
Upside: +17.23%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $31.44
Upside: +46.31%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.57
Upside: +16.73%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $12.00
Upside: +150.00%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $367.34
Upside: -3.36%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $73.76
Upside: +116.92%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $179.04
Upside: +61.97%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.04
Upside: +573.08%